Home8QQ • FRA
add
AbCellera Biologics Inc
Nakaraang pagsara
€1.78
Sakop ng araw
€1.78 - €1.78
Sakop ng taon
€1.70 - €3.79
Market cap
588.01M USD
Average na Volume
448.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.24M | -57.45% |
Gastos sa pagpapatakbo | 24.40M | -4.55% |
Net na kita | -45.62M | -12.34% |
Net profit margin | -1.08K | -164.04% |
Kita sa bawat share | -0.15 | -7.14% |
EBITDA | -57.33M | -14.54% |
Aktuwal na % ng binabayarang buwis | 13.90% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 605.27M | -13.29% |
Kabuuang asset | 1.34B | -8.13% |
Kabuuang sagutin | 321.23M | -3.59% |
Kabuuang equity | 1.02B | — |
Natitirang share | 298.48M | — |
Presyo para makapag-book | 0.52 | — |
Return on assets | -11.58% | — |
Return on capital | -14.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -45.62M | -12.34% |
Cash mula sa mga operasyon | -11.55M | 72.30% |
Cash mula sa pag-invest | 7.94M | -73.47% |
Cash mula sa financing | 5.97M | 110.88% |
Net change in cash | 2.94M | 130.17% |
Malayang cash flow | -63.60M | -21.59% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
596
